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Abstract
Worldwide, 96,000 cases of oropharyngeal cancer (OPC) occurred in 2012. Human papillomavirus (HPV) is a risk factor
for OPC. Data on oropharyngeal HPV infection are limited. There is no consensus on the best sampling method for
detecting the infection. We describe the prevalence of oropharyngeal HPV infection among HIV-infected men and
compare the performance of oral rinses and swabs in detecting oropharyngeal HPV infection. Paired oral rinses and
swabs for 181 men were tested for HPV DNA using the Roche Linear Array. Performance was determined by the
number of infections detected and the percentage of samples with adequate DNA extraction. Agreement between
sampling methods was assessed by the kappa statistic. Prevalence of oropharyngeal HPV infection with rinse samples
was 1.8% (three infections) and 0.6% (one infection) with swabs (p¼ 0.06). Adequate cellular DNA extraction was more
likely with rinse (93.4%) than swab samples (89.0%, p¼ 0.05). There was moderate agreement between the methods
(kappa¼ 0.49). The prevalence of oropharyngeal HPV DNA infection among this predominantly heterosexual sample of
men living with HIV was low and consistent with the infrequent oral sex practices. Oral rinse performed better than oral
swab in detecting oropharyngeal HPV DNA infection and might contribute to screening for OPCs.
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Introduction
Worldwide, an estimated 96,000 cases of oropharyn-
geal cancer (OPC) occurred in 2012,1 with incidence
rising over time.2 The rate of OPCs is about 3–5-fold
higher in men than in women.2 A similar higher rate of
OPC in men than in women was also reported in
South Africa.3
Human papillomavirus (HPV) plays an aetiological
role in OPCs, with 25–50% of OPCs related to HPV.1,2
Oropharyngeal HPV infections mirror the gender pat-
terns of OPCs.4 Higher oropharyngeal HPV prevalence
in men has been ascribed to men being more likely to
smoke, with smoking interfering with mucosal immu-
nity, raising susceptibility to HPV infection. Women
are more likely to generate antibodies following genital
HPV infection than men, with these antibodies offering
some protection against oral HPV infection.4
In addition, women have higher genital HPV viral
loads, making transmission higher with male–female
oral sex than female–male.4 HIV-infected men have a
higher risk for oropharyngeal HPV infection and OPCs
than HIV-negative men.5,6
Data on prevalence of oropharyngeal HPV infection
from low- and middle-income countries are limited.
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The prevalence among healthy men in Brazil was
reported as 2%.7 A study in Pretoria, South Africa
documented a prevalence of 6% among 125 men, of
whom 4% were HIV infected.8 Another study of
34 men in Soweto, South Africa, of whom 9% were
HIV infected, reported a prevalence of 18%.9 It is dif-
ficult to directly compare prevalence estimates, as
sexual orientation, HIV sero-status, sample sizes and
HPV sampling methods vary between studies. Using
baseline data from a cohort of men living with HIV
infection (MLWH) in Johannesburg, South Africa,
we document the prevalence of oropharyngeal HPV
and compare the performance of oral rinses and oral
swabs in detecting these infections.
Methods
The cohort study enrolled 304 men, of whom 181 were
randomly selected for this sub-study using random
numbers generated in Microsoft Excel. Full details of
study procedures are described elsewhere.10 Briefly,
men were enrolled if 18 years or older, HIV-positive
and reported sex in the past three months.10 We col-
lected socio-demographic and behavioural data using a
questionnaire. Participants completed sensitive ques-
tions on sexual behaviour using computer-assisted
self-interview (CASI). The primary aim of the cohort
study was to evaluate the natural history of HPV infec-
tion and disease in HIV-infected men in South Africa
to help inform the selection of HPV prevention inter-
ventions in this population. The sample size of 181 was
deemed adequate to compare the performance of oral
rinse and oral swabs with sensitivity of 70%, specificity
of 90% and precision of 10%. Calculations were based
on oral HPV prevalence of 20%. We assumed that the
prevalence of oropharyngeal HPV infection in men
who were all HIV-positive would be higher than the
18% in men in nearby Soweto, of whom only 9%
were HIV-positive.9 The study was approved by Wits
Human Research Ethics Committee (Approval
number: M111191). Written, informed consent was
obtained from participants after explanation of study
objectives and procedures.
A comprehensive oral examination was conducted
by medical officers, which included inspection of the
gums, tonsillar pillars, tonsils, retropharyngeal wall
and palate. Oral rinses were first collected by asking
participants to gargle 15 mL of normal saline for 15 s
before spitting the fluid into a container and centrifug-
ing it at 3000 r/min for 10 min to obtain sediment.
A cotton swab was then rubbed against the palatine
tonsil and oropharynx. At the same visit, to assess
anogenital-oropharyngeal HPV genotypic concor-
dance, a genital swab was collected by rubbing a
cotton swab around the glans penis, coronal sulcus
and ventral surface of the penis. Intra-anal swabs
were collected by blindly inserting a Dacron swab
3 cm into the anal canal and removing it while rotating
and applying pressure on the walls of the canal. The
swabs and sediment were stored at 70C before HPV
DNA testing. Venous blood was collected for CD4 cell
count and HIV-1 plasma viral load (PVL) testing.
The MagNA Pure LC DNA Isolation Kit I (Roche
Diagnostics, Mannheim, Germany) was used to extract
HPV DNA from the swabs and sediment. HPV geno-
type distributions were assessed by the Roche
Linear Array assay (Roche Diagnostics, Mannheim,
Germany). The human b-globin gene served as an
internal control for cellular adequacy, extraction effi-
ciency and amplification. Therefore, if the internal con-
trol is positive, then HPV will be detected if present. All
HPV test strips were interpreted separately by two
people to minimise reading errors.
Statistical analysis
Fisher’s exact test was used to compare the percentages
of samples with adequate cellular DNA extraction and
HPV DNA positive as well as characteristics of partic-
ipants with and without oropharyngeal HPV infection.
Agreement between the two sampling methods was
assessed by the percentage of crude agreement, defined
as p¼ (aþ d)/N, where a¼number positive by both
assays, d¼number negative by both assays and
N¼ total sample and the kappa statistic. Since the con-
tingency table was unbalanced, we calculated percent-
age positive and negative agreements, defined as a/
[0.5 (Nþ ad)] and d/[0.5 (N aþ d)], respective-
ly.11 StataTM Version 13 was used for all analyses.
Results
The median age was 39 years, with only 2% aged under
25 years (age range: 23–62). More than one-fourth
smoked (28%) and half drank alcohol (53%). Eighty
per cent were taking antiretroviral therapy (ART), of
whom 55% had undetectable PVL. The median
number of life-time sexual partners was 30, with 27%
reporting more than 100 partners. A quarter had had
more than one sexual partner in the preceding three
months (27%). Smaller proportions reported ever
having oral sex: 15% oral-genital and 4% oral-anal
contact. Only 7% reported ever having sex with men
(MSM).
Oral rinse samples were more likely to have ade-
quate cellular DNA extraction than the oral swab sam-
ples (169/181 [93%] vs. 161/181 [89%]; p¼ 0.05). Oral
rinse samples identified three HPV infections, com-
pared to only one with oral swabs (p¼ 0.06). Overall,
82% of the samples gave concordant results,
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kappa¼ 0.09, indicating minimal agreement. When
analysis was restricted to the 151 samples with ade-
quate DNA extraction, there was moderate agreement
between the sampling methods (99%, kappa¼ 0.49).
Corresponding percentages of positive and negative
agreement were 50% and 99%, respectively (Table 1).
Overall, prevalence of HPV DNA was 1.8% (95%
confidence interval: 0.4–5.1%; 3/169). The three partic-
ipants with oropharyngeal infections had high-risk
sexual behaviour. They all reported a sexual debut
aged under 18 years, more than one sexual partner in
the past three months and had not used a condom with
their most recent partner. They were all clinically
stable: on ART for more than 18 months, with CD4
cell count above 500 cells/mL and PVL less than
50 copies/mL. No macroscopic oropharyngeal lesions
were found on examination of these three participants
(Table 2).
We also examined anal and genital samples of the
three men who had oropharyngeal HPV infection
(Table 2). Participant A reported oral-genital contact
and had the same HPV genotype 72 isolated from oral
rinse, oral swab and genital swab, but no infection on
anal swab. Participant B reported sex with other men
and oral-genital contact and the same HPV CP6108
genotype isolated on oral rinse, genital swab and anal
swab samples. Lastly, Participant C did not report oral
sex; the HPV genotype 72 isolated from the oral rinse
differed from the genital HPV genotypes (45, 70), and
anal swab was negative.
Table 1. Agreement between oral rinse and swab sample for HPV DNA detection among 181 male HIV-1
seropositive participants in Johannesburg, South Africa.
Oral rinse þ Oral rinse 
Crude
agreement (%) kappa
Positive
agreement (%)
Negative
agreement (%)
All samplesa (n¼181)
Oral swab þ 1 0 82 0.09 6 90
Oral swab  2 148
Samples with adequate DNA (N¼151)b
Oral swab þ 1 0 99 0.49 50 99
Oral swab  2 148
aIncludes 30 samples that had inadequate cellular DNA extraction as measured by the b-globin gene (18 oral swabs; 8 oral rinses;
2 on both oral rinse and oral swab).
bIncludes only samples that had adequate cellular DNA extraction on both oral swab and rinse.
Table 2. Attributes of three participants with oropharyngeal HPV infection.
Characteristic Participant A Participant B Participant C
Age (years) 44 39 40
Marital status Single Single Single
Currently smokes No No No
Currently drinks alcohol Yes No Yes
Age at sexual debut 17 10 17
Number of sexual partner in past three months 6 15 2
Ever had oral-genital contacta Yes Yes No
Ever had oral-anal contact No No No
Ever had sex with men No Yes No
Consistent condom use with recent partner No No No
Taking ART Yes Yes Yes
Duration on ART (months) 93 54 19
CD4þ cell count, cells/mL 751 655 525
HIV-1 PVL (copies/mL) <40 41 48
Oropharyngeal HPV types isolated HPV 72 HPV CP6108 HPV 72
Genital HPV types isolated HPV 72 HPV CP6108 HPV 45 & HPV 70
Anal HPV types isolated None HPV CP6108 None
Macroscopic oral or oropharyngeal lesion No No No
PVL: plasma viral load; ART: antiretroviral treatment; HPV: human papillomavirus.
aOral-genital refers to oro-penile and oro-vaginal contact.
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Discussion
Our study shows that oropharyngeal HPV prevalence
in this population is low and that the detection of infec-
tion is influenced by sampling method. The prevalence
of infection was similar to the 2% reported among men
in Brazil,7 but is several fold lower than the two previ-
ous estimates from South Africa.8,9 These variations
likely reflect differences in sexual behaviours between
the study populations since all three studies used oral
rinse samples. For example, 80% of men in the Soweto
study reported oral sex compared to only 15% in our
study.5,9 Men in our study reported higher numbers of
lifetime sexual partners than the average (10) docu-
mented for Southern Africa.12 The reason is unclear,
but CASI compared to interviewer-administered ques-
tionnaire (used in the Pretoria study) and self-
administered questionnaire (used in the Soweto study)
could have minimised social desirability bias. This is
plausible because being an MSM is still stigmatised
within South African communities despite the decrim-
inalisation of homosexuality in 1994.13
We found concordant HPV DNA genotypes from
anogenital and oral samples in two participants who
reported oral sex. This supports the contention that
oral sex is responsible for anogenital to oropharyngeal
transmission of HPV infection, and that the observed
rise in OPC associated with HPV may be attributed to
changes in sexual practices.2 This is in keeping with our
finding that the anal or genital HPV infection status per
se was not associated with oropharyngeal infection.
However, HPV auto-inoculation through non-sexual
means, such as contaminated fomites or fingers is pos-
sible.14 It is noteworthy that no HPV type 16 infection,
which is mainly implicated in OPC, was isolated. The
implications of this finding are unclear but could relate
to the generally low prevalence of oropharyngeal HPV
infection among these men who all had no OPC.
Future studies which test the HPV status of histologi-
cally-confirmed OPC cases in South Africa are required
to better understand the role of HPV type 16 in the
causation of these tumours.
Similar to previous studies, we found that oral rins-
ing is better than oral swabbing for ensuring adequate
cellular DNA extraction and detecting oropharyngeal
HPV infection.15 This is likely due to the rinse washing
out exfoliated cells from around the oral cavity, while
oral swabs may be unable to access areas like the ton-
sillar crypts.15 Overall, there was minimal–moderate
agreement between the two sampling methods. The dif-
ference between the high crude agreement and moder-
ate agreement from kappa is explained by the
percentage positive and negative agreements which
show that the main area of disagreement between the
sampling methods was in positive results.11
The main limitations of this study are that it is cross-
sectional and the prevalence of oropharyngeal HPV
infection is low, making it difficult to detect associa-
tions. Additionally, it consisted of mainly heterosexual
HIV-positive men, and findings may not be extrapolat-
ed to other populations. Concordance of genotypes
from anogenital and oral samples does not necessarily
imply that these are the identical viruses and it is pos-
sible that these were two separate infections with the
same HPV type since viral gene sequencing was not
done. Despite these limitations, it contributes literature
on the prevalence of oropharyngeal HPV infection
among men in South Africa and informs decisions
about oropharyngeal sampling.
Conclusion
The prevalence of oropharyngeal infection among this
predominantly heterosexual sample of MLWH was low
and consistent with the infrequent oral sex practices.
Oral rinse performed better than oral swab in detecting
oropharyngeal HPV DNA infection and might contrib-
ute to screening for OPCs.
Key messages
• Prevalence of oropharyngeal infection among this
predominantly heterosexual sample HIV-positive is
low.
• Oral sex is a risk factor for oropharyngeal HPV
infection.
• Oral rinse performed better in detecting oropharyn-
geal HPV DNA infection and might contribute to
screening for OPCs.
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